MiR-155’s metabolic effect was further confirmed in human breast cancer cell lines; in addition, miR-155-high tumors displayed higher glucose uptake in patient samples seen through PET images, with miR-155 correlating negatively and positively with FOXO3a and MYC, respectively. This evidence concerns the gene MYC and breast carcinoma.